pentavalent Dengue/Zika virus vaccine (Bionet-Asia)

N/A

Report date: 2025/03/20 10:09:26

Base Information

Drug Namepentavalent Dengue/Zika virus vaccine (Bionet-Asia)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsZika Virus InfectionDengue
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryThailand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBionet-Asia Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBionet-Asia Co Ltd
Inactive CompaniesN/A
Active IndicationsZika Virus InfectionDengue
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A